Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & EquivalentsCommon EquityCurrent AssetsLiabilities and Shareholders EquityNon-Current AssetsPayablesPrepaid AssetsRetained EarningsShareholder's EquityShares OutstandingTotal Current LiabilitiesTotal LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Tenax Therapeutics (TENX) Intangibles (2016 - 2017)

Tenax Therapeutics' Intangibles history spans 7 years, with the latest figure at $22.0 million for Q3 2017.

  • On a quarterly basis, Intangibles changed 0.0% to $22.0 million in Q3 2017 year-over-year; TTM through Sep 2017 was $22.0 million, a 0.0% change, with the full-year FY2016 number at $22.0 million, changed 0.0% from a year prior.
  • Intangibles hit $22.0 million in Q3 2017 for Tenax Therapeutics, roughly flat from $22.0 million in the prior quarter.
  • Over the last five years, Intangibles for TENX hit a ceiling of $23.5 million in Q1 2015 and a floor of $923397.0 in Q1 2013.
  • Historically, Intangibles has averaged $17.2 million across 5 years, with a median of $22.0 million in 2015.
  • Biggest five-year swings in Intangibles: skyrocketed 2434.6% in 2014 and later fell 6.14% in 2015.
  • Tracing TENX's Intangibles over 5 years: stood at $963810.0 in 2013, then surged by 2289.5% to $23.0 million in 2014, then fell by 4.47% to $22.0 million in 2015, then changed by 0.0% to $22.0 million in 2016, then changed by 0.0% to $22.0 million in 2017.
  • Business Quant data shows Intangibles for TENX at $22.0 million in Q3 2017, $22.0 million in Q4 2016, and $22.0 million in Q3 2016.